Q1 2025 Holdings
Filed 2025-05-15 | 202 holdings | $538.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $45.4M | 939,669 | 8.4% |
| EA Series Trust(BOXX) | ALPHA ARCH 1-3 | 02072L565 | $37.6M | 337,125 | 7.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $35.1M | 3,483,404 | 6.5% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $34.0M | 940,858 | 6.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $16.6M | 968,866 | 3.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $15.7M | 390,729 | 2.9% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $15.1M | 1,486,461 | 2.8% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $13.8M | 2,210,019 | 2.6% |
| Spdr SER TR(BIL) | BLOOMBERG 1-3 MO | 78468R663 | $12.4M | 135,585 | 2.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $11.7M | 339,635 | 2.2% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $11.2M | 5,122,105 | 2.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $9.2M | 207,778 | 1.7% |
| Ishares TR(SHY) | 1 3 YR TREAS BD | 464287457 | $8.5M | 103,337 | 1.6% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $8.1M | 523,767 | 1.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $7.8M | 122,921 | 1.5% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.7M | 750,000 | 1.4% |
| CG Oncology Inc(CGON) | COM | 156944100 | $7.4M | 301,134 | 1.4% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $7.3M | 5,970,768 | 1.4% |
| Janux Therapeutics Inc(JANX)Call | COM | 47103J105 | $7.2M | 264,900 | 1.3% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $6.6M | 1,879,114 | 1.2% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $6.3M | 48,044 | 1.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $6.3M | 177,136 | 1.2% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $6.1M | 1,678,063 | 1.1% |
| AA Mission Acquisition Corp | ORD SHS CL A | G1000R101 | $6.0M | 578,359 | 1.1% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $5.9M | 742,495 | 1.1% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $5.8M | 804,220 | 1.1% |
| Novartis AG(NVSN)Put | SPONSORED ADR | 66987V109 | $5.6M | 50,000 | 1.0% |
| Coherus Biosciences Inc | NOTE 1.500% 4/1 | 19249HAB9 | $5.5M | $5,625,000 | 1.0% |
| Oaktree Acquisition Corp III | UNIT 10/04/2029 | G6717R120 | $5.4M | 516,482 | 1.0% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.3M | 469,729 | 1.0% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $5.2M | 1,471,587 | 1.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $5.1M | 157,079 | 0.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.3M | 127,548 | 0.8% |
| Xencor Inc(XNCR) | COM | 98401F105 | $4.2M | 398,152 | 0.8% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $4.2M | 263,425 | 0.8% |
| Septerna Inc(SEPN) | COM | 81734D104 | $4.2M | 720,848 | 0.8% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $4.2M | 153,767 | 0.8% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $4.0M | $4,500,000 | 0.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $3.9M | 104,853 | 0.7% |
| Savara Inc(SVRA) | COM | 805111101 | $3.8M | 1,360,291 | 0.7% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $3.7M | 100,774 | 0.7% |
| Aerovate Therapeutics Inc | COM | 008064107 | $3.7M | 1,461,234 | 0.7% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $3.7M | 971,100 | 0.7% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $3.6M | 2,801,184 | 0.7% |
| Soleno Therapeutics Inc(SLNO)Put | COM | 834203309 | $3.6M | 50,000 | 0.7% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $3.4M | 641,690 | 0.6% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $3.2M | 1,116,047 | 0.6% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $3.1M | 216,166 | 0.6% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $2.9M | 71,143 | 0.5% |
| Merus N V | COM | N5749R100 | $2.8M | 66,960 | 0.5% |